Onco-Innovations’ Licensed PNKP Inhibitor Technology | IndiaReply

Install our Android app, access all content.

i/Trading

Shubham_mishra

•

about 1 month

Onco-Innovations’ Licensed PNKP Inhibitor Technology Shown to Increase Sensitivity of Cancer Cells to Radiation in Animal Study

[https://x.com/OncoInnovations/status/1889104387177693208](https://x.com/OncoInnovations/status/1889104387177693208)

5

© 2025 Indiareply.com. All rights reserved.